1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Peptide Therapeutics Drugs Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Injection
  • 1.2.3 Oral
  • 1.2.4 Other
• 1.3 Market by Application
  • 1.3.1 Global Peptide Therapeutics Drugs Market Share by Application: 2020 VS 2026
  • 1.3.2 Cancer
  • 1.3.3 Metabolic Disorders
  • 1.3.4 Central Nervous System
  • 1.3.5 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Peptide Therapeutics Drugs Market Perspective (2015-2026)
• 2.2 Global Peptide Therapeutics Drugs Growth Trends by Regions
  • 2.2.1 Peptide Therapeutics Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Peptide Therapeutics Drugs Historic Market Share by Regions (2015-2020)
  • 2.2.3 Peptide Therapeutics Drugs Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Peptide Therapeutics Drugs Players by Market Size
  • 3.1.1 Global Top Peptide Therapeutics Drugs Players by Revenue (2015-2020)
  • 3.1.2 Global Peptide Therapeutics Drugs Revenue Market Share by Players (2015-2020)
• 3.2 Global Peptide Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Peptide Therapeutics Drugs Revenue
• 3.4 Global Peptide Therapeutics Drugs Market Concentration Ratio
  • 3.4.1 Global Peptide Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Peptide Therapeutics Drugs Revenue in 2019
• 3.5 Key Players Peptide Therapeutics Drugs Area Served
• 3.6 Key Players Peptide Therapeutics Drugs Product Solution and Service
• 3.7 Date of Enter into Peptide Therapeutics Drugs Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide Therapeutics Drugs Breakdown Data by Type (2015-2026)

• 4.1 Global Peptide Therapeutics Drugs Historic Market Size by Type (2015-2020)
• 4.2 Global Peptide Therapeutics Drugs Forecasted Market Size by Type (2021-2026)

5 Peptide Therapeutics Drugs Breakdown Data by Application (2015-2026)

• 5.1 Global Peptide Therapeutics Drugs Historic Market Size by Application (2015-2020)
• 5.2 Global Peptide Therapeutics Drugs Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Peptide Therapeutics Drugs Market Size (2015-2026)
• 6.2 North America Peptide Therapeutics Drugs Market Size by Type (2015-2020)
• 6.3 North America Peptide Therapeutics Drugs Market Size by Application (2015-2020)
• 6.4 North America Peptide Therapeutics Drugs Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Peptide Therapeutics Drugs Market Size (2015-2026)
• 7.2 Europe Peptide Therapeutics Drugs Market Size by Type (2015-2020)
• 7.3 Europe Peptide Therapeutics Drugs Market Size by Application (2015-2020)
• 7.4 Europe Peptide Therapeutics Drugs Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Peptide Therapeutics Drugs Market Size (2015-2026)
• 8.2 China Peptide Therapeutics Drugs Market Size by Type (2015-2020)
• 8.3 China Peptide Therapeutics Drugs Market Size by Application (2015-2020)
• 8.4 China Peptide Therapeutics Drugs Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Peptide Therapeutics Drugs Market Size (2015-2026)
• 9.2 Japan Peptide Therapeutics Drugs Market Size by Type (2015-2020)
• 9.3 Japan Peptide Therapeutics Drugs Market Size by Application (2015-2020)
• 9.4 Japan Peptide Therapeutics Drugs Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Peptide Therapeutics Drugs Market Size (2015-2026)
• 10.2 Southeast Asia Peptide Therapeutics Drugs Market Size by Type (2015-2020)
• 10.3 Southeast Asia Peptide Therapeutics Drugs Market Size by Application (2015-2020)
• 10.4 Southeast Asia Peptide Therapeutics Drugs Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

• 11.1 Sanofi
  • 11.1.1 Sanofi Company Details
  • 11.1.2 Sanofi Business Overview
  • 11.1.3 Sanofi Peptide Therapeutics Drugs Introduction
  • 11.1.4 Sanofi Revenue in Peptide Therapeutics Drugs Business (2015-2020))
  • 11.1.5 Sanofi Recent Development
• 11.2 Eli Lilly
  • 11.2.1 Eli Lilly Company Details
  • 11.2.2 Eli Lilly Business Overview
  • 11.2.3 Eli Lilly Peptide Therapeutics Drugs Introduction
  • 11.2.4 Eli Lilly Revenue in Peptide Therapeutics Drugs Business (2015-2020)
  • 11.2.5 Eli Lilly Recent Development
• 11.3 Novo Nordisk
  • 11.3.1 Novo Nordisk Company Details
  • 11.3.2 Novo Nordisk Business Overview
  • 11.3.3 Novo Nordisk Peptide Therapeutics Drugs Introduction
  • 11.3.4 Novo Nordisk Revenue in Peptide Therapeutics Drugs Business (2015-2020)
  • 11.3.5 Novo Nordisk Recent Development
• 11.4 Takeda
  • 11.4.1 Takeda Company Details
  • 11.4.2 Takeda Business Overview
  • 11.4.3 Takeda Peptide Therapeutics Drugs Introduction
  • 11.4.4 Takeda Revenue in Peptide Therapeutics Drugs Business (2015-2020)
  • 11.4.5 Takeda Recent Development
• 11.5 Teva
  • 11.5.1 Teva Company Details
  • 11.5.2 Teva Business Overview
  • 11.5.3 Teva Peptide Therapeutics Drugs Introduction
  • 11.5.4 Teva Revenue in Peptide Therapeutics Drugs Business (2015-2020)
  • 11.5.5 Teva Recent Development
• 11.6 Novartis
  • 11.6.1 Novartis Company Details
  • 11.6.2 Novartis Business Overview
  • 11.6.3 Novartis Peptide Therapeutics Drugs Introduction
  • 11.6.4 Novartis Revenue in Peptide Therapeutics Drugs Business (2015-2020)
  • 11.6.5 Novartis Recent Development
• 11.7 AstraZeneca
  • 11.7.1 AstraZeneca Company Details
  • 11.7.2 AstraZeneca Business Overview
  • 11.7.3 AstraZeneca Peptide Therapeutics Drugs Introduction
  • 11.7.4 AstraZeneca Revenue in Peptide Therapeutics Drugs Business (2015-2020)
  • 11.7.5 AstraZeneca Recent Development
• 11.8 Ipsen
  • 11.8.1 Ipsen Company Details
  • 11.8.2 Ipsen Business Overview
  • 11.8.3 Ipsen Peptide Therapeutics Drugs Introduction
  • 11.8.4 Ipsen Revenue in Peptide Therapeutics Drugs Business (2015-2020)
  • 11.8.5 Ipsen Recent Development
• 11.9 AbbVie
  • 11.9.1 AbbVie Company Details
  • 11.9.2 AbbVie Business Overview
  • 11.9.3 AbbVie Peptide Therapeutics Drugs Introduction
  • 11.9.4 AbbVie Revenue in Peptide Therapeutics Drugs Business (2015-2020)
  • 11.9.5 AbbVie Recent Development
• 11.10 Allergan
  • 11.10.1 Allergan Company Details
  • 11.10.2 Allergan Business Overview
  • 11.10.3 Allergan Peptide Therapeutics Drugs Introduction
  • 11.10.4 Allergan Revenue in Peptide Therapeutics Drugs Business (2015-2020)
  • 11.10.5 Allergan Recent Development
• 11.11 Ferring
  • 10.11.1 Ferring Company Details
  • 10.11.2 Ferring Business Overview
  • 10.11.3 Ferring Peptide Therapeutics Drugs Introduction
  • 10.11.4 Ferring Revenue in Peptide Therapeutics Drugs Business (2015-2020)
  • 10.11.5 Ferring Recent Development
• 11.12 Merck
  • 10.12.1 Merck Company Details
  • 10.12.2 Merck Business Overview
  • 10.12.3 Merck Peptide Therapeutics Drugs Introduction
  • 10.12.4 Merck Revenue in Peptide Therapeutics Drugs Business (2015-2020)
  • 10.12.5 Merck Recent Development
• 11.13 JNJ
  • 10.13.1 JNJ Company Details
  • 10.13.2 JNJ Business Overview
  • 10.13.3 JNJ Peptide Therapeutics Drugs Introduction
  • 10.13.4 JNJ Revenue in Peptide Therapeutics Drugs Business (2015-2020)
  • 10.13.5 JNJ Recent Development
• 11.14 Tarix Pharmaceuticals
  • 10.14.1 Tarix Pharmaceuticals Company Details
  • 10.14.2 Tarix Pharmaceuticals Business Overview
  • 10.14.3 Tarix Pharmaceuticals Peptide Therapeutics Drugs Introduction
  • 10.14.4 Tarix Pharmaceuticals Revenue in Peptide Therapeutics Drugs Business (2015-2020)
  • 10.14.5 Tarix Pharmaceuticals Recent Development
• 11.15 Lonza
  • 10.15.1 Lonza Company Details
  • 10.15.2 Lonza Business Overview
  • 10.15.3 Lonza Peptide Therapeutics Drugs Introduction
  • 10.15.4 Lonza Revenue in Peptide Therapeutics Drugs Business (2015-2020)
  • 10.15.5 Lonza Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Peptide Therapeutics Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peptide Therapeutics Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Injection
Oral
Other

Market segment by Application, split into
Cancer
Metabolic Disorders
Central Nervous System
Other

Based on regional and country-level analysis, the Peptide Therapeutics Drugs market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Peptide Therapeutics Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Sanofi
Eli Lilly
Novo Nordisk
Takeda
Teva
Novartis
AstraZeneca
Ipsen
AbbVie
Allergan
Ferring
Merck
JNJ
Tarix Pharmaceuticals